{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:17:13Z","timestamp":1788891433003,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T00:00:00Z","timestamp":1529712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10067-018-4183-2","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T23:36:09Z","timestamp":1529710569000},"page":"2833-2838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-6422","authenticated-orcid":false,"given":"Masaru","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Yamasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Umeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Nureki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"key":"4183_CR1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/thx.47.11.964","volume":"47","author":"SB Fazel","year":"1992","unstructured":"Fazel SB, Howie SE, Krajewski AS, Lamb D (1992) B lymphocyte accumulations in human pulmonary sarcoidosis. Thorax 47:964\u2013967","journal-title":"Thorax"},{"key":"4183_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0961203306071871","volume":"15","author":"A Becker-Merok","year":"2006","unstructured":"Becker-Merok A, Nikolaisen C, Nossent HC (2006) B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 15:570\u2013576","journal-title":"Lupus"},{"key":"4183_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jbspin.2009.11.005","volume":"77","author":"V Dasilva","year":"2010","unstructured":"Dasilva V, Breuil V, Chevallier P, Euller-Ziegler L (2010) Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case. Joint Bone Spine 77:82\u201383","journal-title":"Joint Bone Spine"},{"key":"4183_CR4","doi-asserted-by":"publisher","first-page":"e5456","DOI":"10.1371\/journal.pone.0005456","volume":"4","author":"M Rauch","year":"2009","unstructured":"Rauch M, Tussiwand R, Bosco N, Rolink AG (2009) Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One 4:e5456","journal-title":"PLoS One"},{"key":"4183_CR5","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/art.21138","volume":"52","author":"W Stohl","year":"2005","unstructured":"Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B, Metzger TE, Bixler SA, Hong YS, Ambrose CM, Mackay F, Morel L, Putterman C, Kotzin BL, Kalled SL (2005) BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum 52:2080\u20132091","journal-title":"Arthritis Rheum"},{"key":"4183_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/ajcp\/75.3.350","volume":"75","author":"LP Pertschuk","year":"1981","unstructured":"Pertschuk LP, Silverstein E, Friedland J (1981) Immunohistologic diagnosis of sarcoidosis. Detection of angiotensin-converting enzyme in sarcoid granulomas. Am J Clin Pathol 75:350\u2013354","journal-title":"Am J Clin Pathol"},{"key":"4183_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1164\/ajrccm\/137.4.759","volume":"137","author":"EC Lawrence","year":"1988","unstructured":"Lawrence EC, Brousseau KP, Berger MB, Kurman CC, Marcon L, Nelson DL (1988) Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Respir Dis 137:759\u2013764","journal-title":"Am Rev Respir Dis"},{"key":"4183_CR8","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","volume":"52","author":"I Ueda-Hayakawa","year":"2013","unstructured":"Ueda-Hayakawa I, Tanimura H, Osawa M, Iwasaka H, Ohe S, Yamazaki F, Mizuno K, Okamoto H (2013) Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity. Rheumatology (Oxford) 52:1658\u20131666","journal-title":"Rheumatology (Oxford)"},{"key":"4183_CR9","doi-asserted-by":"publisher","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","volume":"7","author":"A Saussine","year":"2012","unstructured":"Saussine A, Tazi A, Feuillet S, Rybojad M, Juillard C, Bergeron A, Dessirier V, Bouhidel F, Janin A, Bensussan A, Bagot M, Bouaziz JD (2012) Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS One 7:e43588","journal-title":"PLoS One"},{"key":"4183_CR10","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1373\/49.9.1510","volume":"49","author":"S Rothkrantz-Kos","year":"2003","unstructured":"Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG et al (2003) Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 49:1510\u20131517","journal-title":"Clin Chem"},{"key":"4183_CR11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1378\/chest.129.5.1234","volume":"129","author":"YS Wasfi","year":"2006","unstructured":"Wasfi YS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue Y, Judson MA, Maier LA (2006) A new tool to assess sarcoidosis severity. Chest 129:1234\u20131245","journal-title":"Chest"},{"key":"4183_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1378\/chest.74.3.261","volume":"74","author":"RP Daniele","year":"1978","unstructured":"Daniele RP, McMillan LJ, Dauber JH et al (1978) Immune complexes in sarcoidosis: a correlation with activity and duration of disease. Chest 74:261\u2013264","journal-title":"Chest"},{"key":"4183_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2:465\u2013475","journal-title":"Nat Rev Immunol"},{"key":"4183_CR14","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153\u20132165","journal-title":"N Engl J Med"},{"key":"4183_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jbspin.2008.01.025","volume":"75","author":"A Belkhou","year":"2008","unstructured":"Belkhou A, Younsi R, El Bouchti I et al (2008) Rituximab as a treatment alternative in sarcoidosis. Joint Bone Spine 75:511\u2013512","journal-title":"Joint Bone Spine"},{"key":"4183_CR16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1183\/09031936.98.12030716","volume":"12","author":"J Muller-Quernheim","year":"1998","unstructured":"Muller-Quernheim J (1998) Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 12:716\u2013738","journal-title":"Eur Respir J"},{"key":"4183_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1183\/13993003.00092-2016","volume":"48","author":"Y Kaiser","year":"2016","unstructured":"Kaiser Y, Lepzien R, Kullberg S, Eklund A, Smed-S\u00f6rensen A, Grunewald J (2016) Expanded lung T-bet+RORgammaT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype. Eur Respir J 48:484\u2013494","journal-title":"Eur Respir J"},{"key":"4183_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","volume":"173","author":"LG Ng","year":"2004","unstructured":"Ng LG, Sutherland AP, Newton R et al (2004) B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173:807\u2013817","journal-title":"J Immunol"},{"key":"4183_CR19","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.4049\/jimmunol.167.11.6225","volume":"167","author":"B Huard","year":"2001","unstructured":"Huard B, Schneider P, Mauri D, Tschopp J, French LE (2001) T cell costimulation by the TNF ligand BAFF. J Immunol 167:6225\u20136231","journal-title":"J Immunol"},{"key":"4183_CR20","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.4049\/jimmunol.174.9.5537","volume":"174","author":"AP Sutherland","year":"2005","unstructured":"Sutherland AP, Ng LG, Fletcher CA et al (2005) BAFF augments certain Th1-associated inflammatory responses. J Immunol 174:5537\u20135544","journal-title":"J Immunol"},{"key":"4183_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cytogfr.2013.12.011","volume":"25","author":"M Chen","year":"2014","unstructured":"Chen M, Lin X, Liu Y, Li Q, Deng Y, Liu Z, Brand D, Guo Z, He X, Ryffel B, Zheng SG (2014) The function of BAFF on T helper cells in autoimmunity. Cytokine Growth Factor Rev 25:301\u2013305","journal-title":"Cytokine Growth Factor Rev"},{"key":"4183_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1515\/jomb-2016-0017","volume":"35","author":"S Popevic","year":"2016","unstructured":"Popevic S, Sumarac Z, Jovanovic D et al (2016) Verifying sarcoidosis activity: Chitotriosidase versus ACE in sarcoidosis\u2014a case-control study. J Med Biochem 35:390\u2013400","journal-title":"J Med Biochem"},{"key":"4183_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1378\/chest.124.1.186","volume":"124","author":"JC Grutters","year":"2003","unstructured":"Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JMM, van Velzen-Blad H (2003) Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 124:186\u2013195","journal-title":"Chest"},{"key":"4183_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1465-9921-14-121","volume":"14","author":"R Su","year":"2013","unstructured":"Su R, Nguyen ML, Agarwal MR et al (2013) Interferon-inducible chemokines reflect severity and progression in sarcoidosis. Respir Res 14:121","journal-title":"Respir Res"},{"key":"4183_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/00365510701854975","volume":"68","author":"E Bargagli","year":"2008","unstructured":"Bargagli E, Bianchi N, Margollicci M, Olivieri C, Luddi A, Coviello G, Grosso S, Rottoli P (2008) Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest 68:479\u2013483","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4183-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4183-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T19:11:26Z","timestamp":1561230686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4183-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,23]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4183"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4183-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,23]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}